LORA DILLINGER: Open Payments
NPI 1669926283 · WYOMISSING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,381 in 149 payments from 26 companies in 2025. Trend: 2023 $4,629 · 2024 $3,286 · 2025 $3,381
Food & beverage: $3,244Education: $137
| Company | Payments | Amount |
|---|---|---|
| HARMONY BIOSCIENCES LLC | 20 | $497 |
| GlaxoSmithKline, LLC. | 27 | $442 |
| Insmed, Inc. | 15 | $324 |
| GENZYME CORPORATION | 11 | $293 |
| Regeneron Healthcare Solutions, Inc. | 10 | $258 |
| Verona Pharma, Inc. | 9 | $235 |
| AstraZeneca Pharmaceuticals LP | 2 | $205 |
| Axsome Therapeutics, Inc. | 13 | $189 |
| Merck Sharp & Dohme LLC | 11 | $175 |
| JAZZ PHARMACEUTICALS INC. | 1 | $125 |
Products named: DUPIXENT, WAKIX, Arikayce, TRELEGY ELLIPTA, Ohtuvayre, Sunosi, TEZSPIRE, NUCALA.
Industry payments across PA — which companies pay providers there.
